101 related articles for article (PubMed ID: 17564775)
1. Mizoribine therapy for patients with lupus nephritis: the association between peak mizoribine concentration and clinical efficacy.
Kuroda T; Hirose S; Tanabe N; Sato H; Nakatsue T; Ajiro J; Wada Y; Murakami S; Hasegawa H; Ito S; Sakatsume M; Nakano M; Gejyo F
Mod Rheumatol; 2007; 17(3):206-12. PubMed ID: 17564775
[TBL] [Abstract][Full Text] [Related]
2. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis.
Tanaka H; Tsugawa K; Nakahata T; Kudo M; Suzuki K; Ito E
Clin Nephrol; 2005 Jun; 63(6):417-22. PubMed ID: 15960142
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
Yumura W; Suganuma S; Uchida K; Moriyama T; Otsubo S; Takei T; Naito M; Koike M; Nitta K; Nihei H
Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
[TBL] [Abstract][Full Text] [Related]
4. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
Tanaka H; Tsugawa K; Suzuki K; Nakahata T; Ito E
Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
[TBL] [Abstract][Full Text] [Related]
5. Mizoribine for the treatment of lupus nephritis in children and adolescents.
Tanaka H; Tsugawa K; Tsuruga K; Suzuki K; Nakahata T; Ito E; Waga S
Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
[TBL] [Abstract][Full Text] [Related]
6. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group.
Tanaka H; Oki E; Tsuruga K; Sato N; Matsukura H; Matsunaga A; Kondo Y; Suzuki J
Nephron Clin Pract; 2008; 110(2):c73-9. PubMed ID: 18758186
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of mizoribine in the treatment of systemic lupus erythematosus in children.
Yoshidome K; Takei S; Imanaka H; Maeno N; Ohkawa T; Kawano Y
Pediatr Int; 2004 Aug; 46(4):444-9. PubMed ID: 15310311
[TBL] [Abstract][Full Text] [Related]
8. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis.
Tanaka H; Suzuki K; Nakahata T; Tsugawa K; Ito E; Waga S
Clin Nephrol; 2003 Dec; 60(6):390-4. PubMed ID: 14690255
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis.
Nishi E; Kameda H; Ogawa H; Nagasawa H; Takei H; Okuyama A; Kurasawa T; Kondo T; Nishimura K; Shirai Y; Sakai R; Ito T; Takeuchi T; Amano K
Mod Rheumatol; 2013 Jan; 23(1):97-103. PubMed ID: 22526831
[TBL] [Abstract][Full Text] [Related]
10. Study of the efficacy of mizoribine in lupus nephritis in Chinese patients.
Zhang M; Xing CY; Liu J
Rheumatol Int; 2013 Nov; 33(11):2737-42. PubMed ID: 23797779
[TBL] [Abstract][Full Text] [Related]
11. A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.
Tsubouchi Y; Fukuda W; Kawahito Y; Kohno M; Wada M; Ishino H; Hamaguchi M; Yamamoto A; Kadoya M; Niimi M; Yoshikawa T
Mod Rheumatol; 2008; 18(1):91-5. PubMed ID: 18159569
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic study of mizoribine in an adolescent with lupus nephritis.
Abe Y; Tsuji Y; Hisano M; Nakada M; Miura K; Watanabe S; Odajima Y; Iikura Y
Pediatr Int; 2004 Oct; 46(5):597-600. PubMed ID: 15491391
[No Abstract] [Full Text] [Related]
13. Mizoribine therapy in a patient with lupus nephritis: the association between mizoribine concentration and peritoneal dialysis.
Kuroda T; Kobayashi D; Sato H; Oyanagi A; Wada Y; Murakami S; Nakano M; Narita I
Mod Rheumatol; 2010 Jun; 20(3):296-300. PubMed ID: 20082109
[TBL] [Abstract][Full Text] [Related]
14. Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
Kagawa H; Hiromasa T; Hara T; Takaki A; Yamanaka R; Sada KE; Makino H
Clin Exp Nephrol; 2012 Oct; 16(5):760-6. PubMed ID: 22492013
[TBL] [Abstract][Full Text] [Related]
15. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
Tanaka H; Watanabe S; Aizawa-Yashiro T; Oki E; Kumagai N; Tsuruga K; Ito E
Nephron Clin Pract; 2012; 121(3-4):c165-73. PubMed ID: 23327881
[TBL] [Abstract][Full Text] [Related]
16. Mizoribine requires individual dosing due to variation of bioavailability.
Fuke T; Abe Y; Hibino S; Takeshi M; Saito T; Sakurai S; Watanabe S; Murayama J; Itabashi K; Nakano Y
Pediatr Int; 2012 Dec; 54(6):885-91. PubMed ID: 23039376
[TBL] [Abstract][Full Text] [Related]
17. Long-term intermittent pulse therapy with mizoribine attenuates histologic progression in young patients with severe lupus nephritis: report of two patients.
Tanaka H; Oki ES; Tsugawa K; Suzuki K; Tsuruga K; Ito E
Nephrology (Carlton); 2007 Aug; 12(4):376-9. PubMed ID: 17635753
[TBL] [Abstract][Full Text] [Related]
18. Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome.
Tanaka H; Tsugawa K; Nakahata T; Kudo M; Onuma S; Kimura S; Ito E
Tohoku J Exp Med; 2005 Jan; 205(1):87-91. PubMed ID: 15635277
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.
Uchino A; Tsukamoto H; Nakashima H; Yoshizawa S; Furugo I; Mitoma H; Oryoji K; Shimoda T; Niiro H; Tada Y; Yano T; Nonaka T; Oishi R; Akashi K; Horiuchi T
Clin Exp Rheumatol; 2010; 28(1):6-12. PubMed ID: 20346231
[TBL] [Abstract][Full Text] [Related]
20. Mizoribine selectively attenuates monocyte chemoattractant protein-1 production in cultured human glomerular mesangial cell: a possible benefit of its use in the treatment of lupus nephritis.
Aizawa T; Imaizumi T; Tsuruga K; Watanabe S; Chiba Y; Matsumiya T; Yoshida H; Tanaka H
Nephrology (Carlton); 2014 Jan; 19(1):47-52. PubMed ID: 24134561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
